Amputation Prevention Symposium
The Amputation Prevention Symposium (AMP) is the premier multidisciplinary forum dedicated to advancing the treatment of chronic limb-threatening ischemia (CLTI). With a mission to save limbs and lives, AMP drives innovation, collaboration, and education in limb preservation.
Through hands-on workshops, live cases, and dynamic discussions, AMP brings together emerging leaders and experienced experts to share groundbreaking technologies and shape the future of CLTI care. It’s where advocacy meets action—empowering clinicians to improve outcomes and offer hope to patients worldwide.
HMP Global
For 40 years, the company has built trusted brands including Psych Congress, the premier source for mental health education, and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP Global partners with leading experts around the world to deliver more than 450 annual events, medical strategy and marketing for pharmaceutical and medical device customers through HMP Collective, and pharmaceutical market insight, engaging a global community of healthcare stakeholders that includes nearly 2 million clinicians across 600 medical specialties as well as managed care, behavioral health, senior living, emergency medical, and pharmaceutical commercialization professionals.
Website:
www.hmpglobal.com
Benefits
After attending AMP, participants should be better able to:
• Apply a comprehensive, multidisciplinary best-practice approach for patients with advanced peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI) who are at risk for major amputation.
• Describe the magnitude of CLTI and amputation and efforts necessary to decrease unnecessary
amputations in at-risk populations.
• Describe the decision algorithm for treatment decisions for patients with CLTI to include endovascular, surgical, and hybrid options.
• Describe the role of atherectomy in CLTI and its application in amputation prevention.
• Treat complex chronic total occlusions in tibial and pedal arterial vessels in the patient with CLTI.
• Describe arterial angiosome anatomy in conjunction with cutaneous and ultrasonic angiosome mapping in patients with advanced tibiopedal arterial disease who are at risk for major amputation.
• Implement procedural and technological advances in wound care practices for patients facing major
amputation due to advanced PAD, advanced non-healing wounds, and gangrene.
• Identify the components necessary to build a multidisciplinary amputation-prevention program.
• Implement a diagnostic algorithm that includes selective angiography as a critical step for patients with CLTI who are at risk for amputation.
• Incorporate advanced tibiopedal access in combination with antegrade access in limb salvage
procedures.
• Describe tips and tricks for safe and effective surgical and endovascular treatment of CLTI, from access to closure.
• Describe unique considerations when evaluating the diabetic foot ulcer in the setting of CLTI.
• Describe modern core wound principles for the CLTI practitioner.
• Describe currently available drug-eluting technology for the treatment of above-the-knee and below-the-knee lesions in the patient with CLTI.
• Describe current wire, catheter, balloon, crossing, atherectomy, re-entry, and closure devices available for treatment of CLTI, and describe mechanism of action and when most appropriate to utilize.
Product features
Certification preparation
CEU certificate available
Clinical decision tools
Online learning platform
Onsite training
Other features
Educational Material Available
Free Samples/Trials Available
Published Clinical Article Available
No posters match your selected filters. Remove some filtres, or reset them and start again.
Have a product to submit?
Be included in the most comprehensive wound care products directory
and online database.
Learn More